Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical evaluation of oligonucleotide microarrays for the detection of HBV mutants associated with lamivudine resistance.

Pharmacogenomics - 1 Oct 2005

Chen Li-Yan, Huang Jian, Zhang Xin-Ping, Qiao Ping, Zhang Wen, Yang Ning-Min, Liu Hong-Jing, Geng Yong-Yao, Qiu Jian-Ming, Wang Sheng-Qi

Abstract excerpt

OBJECTIVES: Long-term lamivudine administration in hepatitis B virus (HBV)-infected patients induces the emergence of HBV mutants with lamivudine resistance. The aim of the present study was to evaluate the clinical application of an oligonucleotide microarray in detecting HBV mutants associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Viral
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Lamivudine

Share to Oligonucleotide Array Sequence Analysis

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 16207149
DOI: 10.2217/14622416.6.7.721

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16207149-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical evaluation of oligonucleotide microarrays for the detection of HBV mutants associated with lamivudine resistance.PMID 16207149Read ↗

Quantification of the relative levels of wild-type and lamivudine-resistant mutant virus in serum of HBV-infected patients using microarray.Semantic proximity Read ↗

[Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].Semantic proximity Read ↗

Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.Semantic proximity Read ↗

[Detection and identification of HBV DNA YMDD motif mutation during lamivudine treatment using oligonucleotide array].Semantic proximity Read ↗

Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.Semantic proximity Read ↗

Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance.Semantic proximity Read ↗

Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.Semantic proximity Read ↗

[Detection and identification of emergence of HBV YMDD motif mutation during lamivudine treatment by hybridization to an oligonucleotide array].Semantic proximity Read ↗

Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy.Semantic proximity Read ↗

Rapid detection of the hepatitis B virus YMDD mutant using AllGlo™ probes.Semantic proximity Read ↗

Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.Semantic proximity Read ↗

[Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.